Clinical Trial Update: Phase III Study Treatment of CLL B and C [Phase 3]

View source ↗

Summary

Phase III trial evaluating treatment for Chronic Lymphocytic Leukemia (CLL) B and C has completed. Sponsor: French Innovative Leukemia Organisation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Leukemia, Lymphocytic, Chronic | Phase 3 | Status: COMPLETED